Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash Flows From Operating Activities
Net loss	$ (4,355,820)	$ (7,684,317)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	7,047	9,422
Amortization of patents	335,560	335,560
Issuance of stock for services	80,000
Changes in operating assets and liabilities
Settlement receivable	(533,926)	183,329
Other current assets	126,864	115,565
Accounts payable - trade	229,962	1,354,439
Other accrued expenses	635,169	98,098
Net Cash Used In Operating Activities	(3,475,145)	(5,587,904)
Cash Flows From Financing Activities
Proceeds from issuance of convertible notes payable	1,956,000	2,550,000
Proceeds from issuance of convertible notes payable - related party	950,000	3,000,000
Proceeds from exercise of warrants	594,274
Net Cash Provided By Financing Activities	3,500,274	5,550,000
Net Change In Cash and Cash Equivalents	25,129	(37,904)
Cash and Cash Equivalents, Beginning of Period	105,504	1,165,738
Cash and Cash Equivalents, End of Period	130,633	1,127,834
Non-cash investing and financing activities:
Conversion of preferred stock into common stock		3,987
Dividend paid-in kind to preferred shareholders		1,595
Issuance in-kind of preferred stock dividends		$ 14,057